Daniel D. Von Hoff
Translational Genomics Research Institute(US)Radiation Oncology Institute(US)City of Hope(US)HonorHealth(US)
Publications by Year
Research Areas
Pancreatic and Hepatic Oncology Research, Cancer Genomics and Diagnostics, Cancer Treatment and Pharmacology, Cancer therapeutics and mechanisms, Epigenetics and DNA Methylation
Most-Cited Works
- → Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine(2013)6,560 cited
- → Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.(1997)5,865 cited
- → Risk Factors for Doxorubicin-lnduced Congestive Heart Failure(1979)2,419 cited
- → Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal Adenocarcinoma(2012)2,073 cited
- → Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial(2015)1,174 cited
- → Hypersensitivity reactions from taxol.(1990)1,172 cited